Walvax Biotechnology Co., Ltd. (SHE:300142)
10.09
-0.06 (-0.59%)
Apr 25, 2025, 2:45 PM CST
Walvax Biotechnology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 24, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 16,217 | 19,320 | 37,601 | 64,274 | 89,423 | 59,516 | Upgrade
|
Market Cap Growth | -48.62% | -48.62% | -41.50% | -28.12% | 50.25% | 19.33% | Upgrade
|
Enterprise Value | 15,024 | 18,563 | 36,117 | 62,959 | 88,584 | 58,587 | Upgrade
|
Last Close Price | 10.14 | 12.08 | 23.49 | 40.15 | 56.11 | 38.47 | Upgrade
|
PE Ratio | 114.06 | 135.90 | 89.66 | 88.21 | 209.06 | 59.33 | Upgrade
|
Forward PE | 40.56 | 37.75 | 42.75 | 54.68 | 56.13 | 42.78 | Upgrade
|
PS Ratio | 5.75 | 6.85 | 9.14 | 12.64 | 25.82 | 20.25 | Upgrade
|
PB Ratio | 1.41 | 1.68 | 3.30 | 5.85 | 8.94 | 7.58 | Upgrade
|
P/TBV Ratio | 1.94 | 2.31 | 4.57 | 8.15 | 11.16 | 9.54 | Upgrade
|
P/FCF Ratio | 33.34 | 39.71 | 199.74 | 582.65 | - | - | Upgrade
|
P/OCF Ratio | 15.65 | 18.64 | 33.16 | 53.50 | 126.79 | 521.18 | Upgrade
|
EV/Sales Ratio | 5.32 | 6.58 | 8.78 | 12.38 | 25.58 | 19.93 | Upgrade
|
EV/EBITDA Ratio | 36.42 | 47.89 | 32.22 | 44.27 | 95.49 | 51.04 | Upgrade
|
EV/EBIT Ratio | - | 773.04 | 43.46 | 53.63 | 111.82 | 57.22 | Upgrade
|
EV/FCF Ratio | 30.88 | 38.16 | 191.86 | 570.72 | - | - | Upgrade
|
Debt / Equity Ratio | 0.04 | 0.04 | 0.07 | 0.04 | 0.03 | 0.01 | Upgrade
|
Debt / EBITDA Ratio | 1.19 | 1.19 | 0.70 | 0.32 | 0.34 | 0.03 | Upgrade
|
Debt / FCF Ratio | 1.01 | 1.01 | 4.28 | 4.19 | - | - | Upgrade
|
Asset Turnover | 0.19 | 0.19 | 0.27 | 0.35 | 0.30 | 0.35 | Upgrade
|
Inventory Turnover | 0.83 | 0.83 | 0.74 | 0.72 | 0.60 | 1.02 | Upgrade
|
Quick Ratio | 2.63 | 2.63 | 2.37 | 2.24 | 2.07 | 3.00 | Upgrade
|
Current Ratio | 2.98 | 2.98 | 2.73 | 2.55 | 2.37 | 3.36 | Upgrade
|
Return on Equity (ROE) | 1.52% | 1.52% | 4.57% | 8.94% | 6.74% | 17.93% | Upgrade
|
Return on Assets (ROA) | 0.10% | 0.10% | 3.36% | 5.06% | 4.25% | 7.68% | Upgrade
|
Return on Capital (ROIC) | 0.12% | 0.12% | 4.39% | 6.74% | 5.44% | 9.44% | Upgrade
|
Return on Capital Employed (ROCE) | 0.20% | 0.20% | 6.70% | 9.90% | 7.60% | 12.50% | Upgrade
|
Earnings Yield | 0.88% | 0.74% | 1.11% | 1.13% | 0.48% | 1.69% | Upgrade
|
FCF Yield | 3.00% | 2.52% | 0.50% | 0.17% | -0.45% | -0.49% | Upgrade
|
Dividend Yield | 0.10% | 0.08% | 0.04% | 0.03% | 0.05% | 0.18% | Upgrade
|
Payout Ratio | 28.80% | 28.80% | 4.76% | 6.88% | 19.48% | 3.16% | Upgrade
|
Buyback Yield / Dilution | 0.06% | 0.06% | 0.21% | -1.93% | -0.90% | -1.37% | Upgrade
|
Total Shareholder Return | 0.16% | 0.15% | 0.26% | -1.91% | -0.85% | -1.18% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.